C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/04 (2006.01) A61K 39/165 (2006.01) C07K 14/12 (2006.01) C07K 14/135 (2006.01)
Patent
CA 2323927
Isolated, recombinantly-generated, attenuated measles viruses and respiratory syncytial subgroup B viruses having defined attenuating mutations are described. Vaccines are formulated comprising such viruses and a physiologically acceptable carrier. The vaccines are used for immunizing an individual to induce protection against measles virus or respiratory syncytial subgroup B virus.
L'invention concerne le virus de la rougeole et le virus respiratoire syncytial humain du sous-groupe B, ces virus étant isolés, générés par recombinaison et atténués et présentant des mutations d'atténuation définies. L'invention concerne également des formulations de vaccins comprenant ces virus et un excipient physiologiquement acceptable. Les vaccins s'utilisent pour immuniser un individu et le protéger contre le virus de la rougeole ou le virus respiratoire syncytial humain du sous-groupe B.
Buonagurio Deborah A.
Randolph Valerie B.
Sidhu Mohinderjit S.
Udem Stephen A.
American Cyanamid Company
Smart & Biggar
Wyeth Holdings Corporation
LandOfFree
Mutations responsible for attenuation in measles virus or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutations responsible for attenuation in measles virus or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutations responsible for attenuation in measles virus or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1360644